Table 2.

MARV GP clearance by LAP (data for Fig. 4): GP concentration (%) vs. time from 4 experiments. LAP I–III show MARV GP in complete medium, LAP IV (S) was MARV GP in human donor serum. Controls (n = 4): LAP devices without GNA

Time, min	Concentration, %
	LAP I	Control I	LAP II	Control II	LAP III	Control III	LAP IV (S)	Control IV (S)
0	100	100	100	100	100	100	100	100
30	37.5	79.9	39	83.5	42.3	89.8	55	93
60	27.3	82.4	34.6	81.1	38.6	89.1	46.5	87.8
90	34.2	78.1	39.4	86	38.2	83.2	46.9	89
120	28.5	81.2	30.4	83.1	32.5	86.4	45.8	88.1
150	20.8	76.8	24.6	85	39.3	86.1	39.6	91.8
180	17.8	78.5	23.3	83.8	34.6	86.5	42.6	94.4